Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120670934 | 12067093 | 4 | F | 20160105 | 20160909 | 20160211 | 20160918 | EXP | FR-009507513-1602FRA003812 | MERCK | 67.22 | YR | M | Y | 0.00000 | 20160918 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120670934 | 12067093 | 1 | PS | TEMODAL | TEMOZOLOMIDE | 1 | Oral | 2 X 60 MG DURING 5 DAYS | Y | 21029 | 60 | MG | CAPSULE | BID | |||||
| 120670934 | 12067093 | 2 | SS | IMODIUM | LOPERAMIDE HYDROCHLORIDE | 1 | Oral | AFTER EACH LIQUID STOOL | Y | U | 0 | ||||||||
| 120670934 | 12067093 | 3 | SS | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | UNK, TIW | U | 0 | TIW | ||||||||
| 120670934 | 12067093 | 4 | SS | SOLUPRED | PREDNISOLONE | 1 | Oral | 3 TAB AT 20 MG IN THE MORNING | U | 0 | 60 | MG | QD | ||||||
| 120670934 | 12067093 | 5 | SS | ZOPHREN (ondansetron) | ONDANSETRON | 1 | Oral | UNK | U | 0 | |||||||||
| 120670934 | 12067093 | 6 | SS | SPASFON | PHLOROGLUCINOL | 1 | Oral | 80 MG, TID | U | 0 | 80 | MG | TID | ||||||
| 120670934 | 12067093 | 7 | SS | SMECTA | MONTMORILLONITE | 1 | Oral | 2 AT NOON | Y | U | 0 | 2 | DF | QD | |||||
| 120670934 | 12067093 | 8 | C | INEGY | EZETIMIBESIMVASTATIN | 1 | Oral | UNK | U | 0 | TABLET | ||||||||
| 120670934 | 12067093 | 9 | C | DIFFU-K | POTASSIUM CHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 120670934 | 12067093 | 10 | C | INEXIUM (esomeprazole magnesium) | ESOMEPRAZOLE MAGNESIUM | 1 | UNK | U | 0 | ||||||||||
| 120670934 | 12067093 | 11 | C | LERCAN | LERCANIDIPINE | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120670934 | 12067093 | 1 | Glioblastoma |
| 120670934 | 12067093 | 2 | Diarrhoea |
| 120670934 | 12067093 | 5 | Vomiting |
| 120670934 | 12067093 | 6 | Gastrointestinal disorder |
| 120670934 | 12067093 | 7 | Gastrointestinal disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120670934 | 12067093 | OT |
| 120670934 | 12067093 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120670934 | 12067093 | Gastrointestinal disorder | |
| 120670934 | 12067093 | Intussusception |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120670934 | 12067093 | 1 | 20140522 | 201512 | 0 | |
| 120670934 | 12067093 | 2 | 20151222 | 201601 | 0 | |
| 120670934 | 12067093 | 6 | 20151222 | 0 | ||
| 120670934 | 12067093 | 7 | 20151222 | 201601 | 0 |